Clinical Trials in Portland

Showing 581-600 of 8,670 trials

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

NCT05397496

This is an open-label, multicenter, phase I study, which primary objective is to characterize the safety and tolerability of PIT565 and to identify maximal tolerated doses (MTDs) and/or recommended doses (RDs), schedule and route of administration in relapsed and/or refractory B-cell Non-Hodgkin lymphoma (R/R B-NHL) and relapsed and/or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL).

B-cell Non-Hodgkin Lymphoma (B-NHL)B-cell Acute Lymphoblastic Leukemia (B-ALL)

Novartis Pharmaceuticals61 participantsStarted Oct 2022

Miami, Florida, United States • Chicago, Illinois, United States • Fairway, Kansas, United States +15 more locations

Active Not RecruitingNA< 1 mile

Evolut™ EXPAND TAVR II Pivotal Trial

NCT05149755

Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.

Moderate Aortic Valve Stenosis

Medtronic Cardiovascular650 participantsStarted Apr 2022

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +91 more locations

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

Evolut™ EXPAND TAVR II Pivotal Trial

Find Trials by Condition in Portland

A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

Improving Medical Decision Making for Older Patients With End Stage Renal Disease

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV

A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

Hip Arthroscopy Versus Total Hip Arthroplasty RCT

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

ELEVATE High-Risk PCI Pivotal Study

An International Observational Study of Adults With Acute Infection

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors